Daiichi Sankyo Company, Limited

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited (第一三共株式会社, 4568), Pharmaceutical. 17 cross-shareholdings, a board of 15 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YZB3, filed 2026-08-28. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-311,044.967.02,221.434.9427.0016,458
2023-03-311,278.5109.22,508.956.9630.0017,435
2024-03-311,601.7200.73,461.1104.6950.0018,726
2025-03-311,886.3295.83,456.1155.9660.0019,765
2026-03-312,123.0279.73,996.3151.1778.0020,171

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Shizuoka Financial Group, Inc.5,449,00014.01.0
Cuorips Inc.1,000,0007.012.1
Ultragenyx Pharmaceutical Inc.1,243,9134.2—
MS&AD Insurance Group Holdings, Inc.659,0892.70.0
Qol Holdings Co.,Ltd.1,304,0002.43.5
Tokio Marine Holdings, Inc.229,8001.70.0
KISSEI PHARMACEUTICAL CO., LTD.313,0001.50.8
Iyogin Holdings, Inc.470,0001.30.2
AIN HOLDINGS INC.114,0000.60.3
HOKUYAKU TAKEYAMA Holdings,Inc.438,5000.42.1

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown